Ergocalciferol (BioDeep_00000000187)

 

Secondary id: BioDeep_00000398713

natural product human metabolite PANOMIX_OTCML-2023 Endogenous blood metabolite BioNovoGene_Lab2019


代谢物信息卡片


(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol

化学式: C28H44O (396.3392)
中文名称: 麦角钙化 (甾) 醇, 维生素 D2, 维生素D2, α-骨化醇, 麦角骨化醇, 麦化骨化醇, 骨化醇, 丁二素, alpha-骨化醇, 麦角钙化甾醇
谱图信息: 最多检出来源 Homo sapiens(otcml) 19.33%

分子结构信息

SMILES: C1C(=C)/C(=C\C=C2\[C@]3([H])CC[C@@]([H])([C@@]3(C)CCC\2)[C@]([H])(C)/C=C/[C@H](C)C(C)C)/C[C@@H](O)C1
InChI: InChI=1/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1

描述信息

Ergocalciferol appears as odorless white crystals. Used as a dietary supplement and food additive. (EPA, 1998)
Vitamin D2 is a vitamin D supplement and has been isolated from alfalfa. It has a role as a nutraceutical, a bone density conservation agent, a rodenticide and a plant metabolite. It is a seco-ergostane, a hydroxy seco-steroid and a vitamin D.
Ergocalciferol is an inactivated vitamin D analog. It is synthesized by some plants in the presence of UVB light. The production of ergocalciferol was prompted by the identification of dietary deficiency, more specifically vitamin D, as the main causative factor for the development of rickets. Ergocalciferol was isolated for the first time from yeast in 1931 and its structure was elucidated in 1932. Ergocalciferol is considered the first vitamin D analog and is differentiated from [cholecalciferol] by the presence of a double bond between C22 and C23 and the presence of a methyl group at C24. These modifications reduce the affinity of ergocalciferol for the vitamin D binding protein resulting in faster clearance, limits its activation, and alters its catabolism. The first approved product containing ergocalciferol under the FDA records was developed by US Pharm Holdings and was FDA approved in 1941.
Ergocalciferol is a Provitamin D2 Compound.
Ergocalciferol is a natural product found in Pseudo-nitzschia multistriata, Humulus lupulus, and other organisms with data available.
Ergocalciferol is vitamin D2, a fat-soluble vitamin important for many biochemical processes including the absorption and metabolism of calcium and phosphorus. In vivo, ergocalciferol is formed after sun (ultraviolet) irradiation of plant-derived ergosterol, another form of vitamin D. Ergocalciferol is the form of vitamin D usually found in vitamin supplements. (NCI04)
Ergocalciferol is a form of Vitamin D, also called vitamin D2. It is created from viosterol, which in turn is created when ultraviolet light activates ergosterol. Ergocalciferol is used in the treatment of hypcalcemia and in dialysis-dependent renal failure. Ergoalcifediol is a fat soluble steroid hormone precursor of vitamin D that contributes to the maintenance of normal levels of calcium and phosphorus in the bloodstream. Vitamin D2 is the form of vitamin D most commonly added to foods and nutritional supplements. Vitamin D2 must be transformed (hydroxylated) into one of two active forms via the liver or kidney. Once transformed, it binds to the vitamin D receptor that then leads to a variety of regulatory roles.
Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.
See also: ... View More ...
Ergocalciferol is a form of Vitamin D, also called vitamin D2. It is created from viosterol, which in turn is created when ultraviolet light activates ergosterol. Ergocalciferol is used in the treatment of hypcalcemia and in dialysis-dependent renal failure. Ergoalcifediol is a fat soluble steroid hormone precursor of vitamin D that contributes to the maintenance of normal levels of calcium and phosphorus in the bloodstream. Vitamin D2 is the form of vitamin D most commonly added to foods and nutritional supplements. Vitamin D2 must be transformed (hydroxylated) into one of two active forms via the liver or kidney. Once transformed, it binds to the vitamin D receptor that then leads to a variety of regulatory roles.
A - Alimentary tract and metabolism > A11 - Vitamins > A11C - Vitamin a and d, incl. combinations of the two > A11CC - Vitamin d and analogues
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials
D018977 - Micronutrients > D014815 - Vitamins > D004872 - Ergocalciferols
A vitamin D supplement and has been isolated from alfalfa.
D000077264 - Calcium-Regulating Hormones and Agents
D050071 - Bone Density Conservation Agents
Antirachitic vitamin
Corona-virus
Coronavirus
SARS-CoV-2
COVID-19
SARS-CoV
COVID19
SARS2
SARS
Acquisition and generation of the data is financially supported in part by CREST/JST.

同义名列表

182 个代谢物同义名

(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol; Cyclohexanol, 4-methylene-3-((2E)-2-((1R,3aS,7aR)-octahydro-7a-methyl-1-((1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl)-4H-inden-4-ylidene)ethylidene)-, (1S,3Z)-; Cyclohexanol, 4-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-, (1S,3Z)-; (1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol; (S,Z)-3-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-Dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol; CYCLOHEXANOL, 4-METHYLENE-3-(2-(TETRAHYDRO-7A-METHYL-1-(1,4,5-TRIMETHYL-2-HEXENYL)-4(3AH)-INDANYLIDENE)ETHYLIDENE)-; 4-methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol; Ergocalciferol (Vitamin D2), Pharmaceutical Secondary Standard; Certified Reference Material; Ergocalciferol for system suitability, EuropePharmacopoeia (EP) Reference Standard; 24-METHYL-9,10-SECOCHOLESTA-5,7,10( 19),22-TETRAENE-3.BETA.-OL [WHO-IP]; Ergocalciferol, United States Pharmacopeia (USP) Reference Standard; 9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol, (3.beta.,5Z,7E,22E)-; (3.BETA.,5Z,7E,22E)-9,10-SECOERGOSTA-5,7,10(19),22-TETRAEN-3-OL; (3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol; 9,10-SECOERGOSTA-5,7,10(19),22-TETRAEN-3-OL,(3-BETA,5Z,7E,22E)-; 9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol, (3beta,5Z,7E,22E)-; Ergocalciferol, European Pharmacopoeia (EP) Reference Standard; Ergocalciferol, British Pharmacopoeia (BP) Reference Standard; (3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol; 9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol, (3b,5Z,7E,22E)-; (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol; (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol; 24-METHYL-9,10-SECOCHOLESTA-5,7,10(19),22-TETRAENE-3beta-OL; (3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol; (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol; (3Β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol; (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol; 9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol; (5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol; Ergocalciferol, >=98.0\\% (sum of enantiomers, HPLC); 9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol; 9,10,SECOERGOSTA-5,7,10(19),22-TETRAEN 3-BETA-OL; 22-tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol; 9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol; Irradiated ergosta-5,7,22-trien-3-beta-ol; Irradiated ergosta-5,7,22-trien-3beta-ol; Ergocalciferol (D2), analytical standard; Ergocalciferol, Sigma Reference Standard; Ergocalciferol, 40,000,000 USP units/g; Vitamin D2; Ergocalciferol; Deltalin; 7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87; Ergocalciferol (USP:INN:BAN:JAN); Ergocalciferol [USP:INN:BAN:JAN]; ERGOCALCIFEROLUM [WHO-IP LATIN]; ERGOCALCIFEROL [USP MONOGRAPH]; ERGOCALCIFEROL (USP MONOGRAPH); ERGOCALCIFEROL (EP MONOGRAPH); ERGOCALCIFEROL [EP MONOGRAPH]; ERGOCALCIFEROL [ORANGE BOOK]; Ergocalciferolum [INN-Latin]; ERGOCALCIFEROL [EP IMPURITY]; Ergocalciferolum (INN-Latin); ERGOCALCIFEROL (EP IMPURITY); MECHNRXZTMCUDQ-RKHKHRCZSA-N; Vitamin D2 (Ergocalciferol); Doral [Vitamin Derivative]; Vitamin d (ergocalciferol); Ergocalciferol (JP17/USP); Oleovitamin D, Synthetic; Ergocalciferol Capsules,; ergocalciferol; 50-14-6; ERGOCALCIFEROL [USP-RS]; ERGOCALCIFEROL [WHO-DD]; ERGOCALCIFEROL [WHO-IP]; ERGOCALCIFEROL (USP-RS); ERGOCALCIFEROL [MART.]; ERGOCALCIFEROL (MART.); Ergosterol, irradiated; Ergocalciferolo [DCIT]; ERGOCALCIFEROL [VANDF]; ERGOCALCIFEROL [HSDB]; Ergosterol irradiated; ERGOCALCIFEROL [INCI]; Irradiated ergosterol; ERGOCALCIFEROL [INN]; ERGOCALCIFEROL [JAN]; Shock-ferol sterogyl; ERGOCALCIFEROL, (+)-; Ergosterol activated; Activated ergosterol; VITAMIN D2 [WHO-IP]; Synthetic Vitamin D; De-rat concentrate; Ergocalciferol oil; Geltabs Vitamin D; Prestwick3_000420; VITAMIN D2 [FCC]; Viosterol in oil; Ergocalciferolum; delta-Tracetten; Ergocalciferolo; VITAMIN D2 [MI]; Calciferol (TN); Ergocalciferols; Ergocalciferol; (+)-Vitamin D2; Oleovitamin D2; Novovitamin-D; MEGxm0_000466; Oleovitamin D; BPBio1_000418; Calciferon 2; delta-Arthin; vitaminum d2; ACon1_002187; Calciferolum; Sterogyl 15H; Drisdol (TN); Sterogyl-15; Uvesterol D; Vitamina D2; D-Tracetten; Eciferol D2; D2, Vitamin; Crystallina; Davitamon D; Uvesterol-D; Calciferols; Dee-Osterol; Vitamin D 2; Shock-ferol; Divit urto; Vitamin D2; Hi-Deratol; Mulsiferol; Sorex C.R.; Ergoral D2; Calciferol; Radiostol; Ercalciol; Viostdrol; Radsterin; Vitavel-D; Dee-Ronal; Condacaps; Viosterol; Dee-Roual; VitaminD2; Condocaps; D-Arthin; Ergorone; Mykostin; Fortodyl; Rodine C; Deltalin; Radstein; Sterogyl; Hyperkil; Geltabs; Drisdol; Osto-D2; Metadee; A11CC01; Dee-Ron; Detalup; D-forte; Haliver; Ostelin; beta-ol; Rodinec; Mina D2; Vitamin; Deratol; Davitin; Disdrol; Diactol; Ergo-D2; Decaps; Ertron; Condol; Buco-D; Crtron; Osteil; Infron; Lanes; Daral; Doral; Vio D; Vio-D; VD2-D3; Vitamin D2



数据库引用编号

34 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

41 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 9 ALB, BGLAP, CALCA, CYP27B1, CYP2R1, CYP3A4, EGFR, FGF23, VDR
Peripheral membrane protein 2 CYP11A1, CYP27A1
Endosome membrane 1 EGFR
Endoplasmic reticulum membrane 3 CYP2R1, CYP3A4, EGFR
Mitochondrion membrane 3 CYP11A1, CYP27A1, CYP27B1
Nucleus 3 ALB, EGFR, VDR
cytosol 2 ALB, VDR
dendrite 1 BGLAP
centrosome 1 ALB
nucleoplasm 1 VDR
RNA polymerase II transcription regulator complex 1 VDR
Cell membrane 2 EGFR, TNF
ruffle membrane 1 EGFR
Early endosome membrane 1 EGFR
cell junction 1 EGFR
cell surface 3 EGFR, EPO, TNF
glutamatergic synapse 1 EGFR
Golgi apparatus 1 ALB
Golgi membrane 2 EGFR, INS
mitochondrial inner membrane 3 CYP11A1, CYP24A1, CYP27A1
neuronal cell body 2 CALCA, TNF
endosome 1 EGFR
plasma membrane 3 EGFR, IFNLR1, TNF
terminal bouton 1 CALCA
Membrane 4 CYP11A1, CYP3A4, EGFR, IFNLR1
apical plasma membrane 1 EGFR
basolateral plasma membrane 1 EGFR
extracellular exosome 2 ALB, EPO
endoplasmic reticulum 1 ALB
extracellular space 12 ALB, BGLAP, CALCA, CRP, EGFR, EPO, FGF23, IL10, IL6, INS, PTH, TNF
perinuclear region of cytoplasm 1 EGFR
mitochondrion 4 CYP11A1, CYP24A1, CYP27A1, CYP27B1
protein-containing complex 2 ALB, EGFR
intracellular membrane-bounded organelle 2 CYP2R1, CYP3A4
Microsome membrane 2 CYP2R1, CYP3A4
Single-pass type I membrane protein 2 EGFR, IFNLR1
Secreted 9 ALB, BGLAP, CALCA, CRP, EPO, FGF23, IL10, IL6, INS
extracellular region 11 ALB, BGLAP, CALCA, CRP, EPO, FGF23, IL10, IL6, INS, PTH, TNF
mitochondrial outer membrane 1 CYP27B1
hippocampal mossy fiber to CA3 synapse 1 CALCA
mitochondrial matrix 2 CYP11A1, CYP27A1
anchoring junction 1 ALB
nuclear membrane 1 EGFR
external side of plasma membrane 1 TNF
perikaryon 1 BGLAP
recycling endosome 1 TNF
Single-pass type II membrane protein 1 TNF
vesicle 1 BGLAP
Mitochondrion inner membrane 2 CYP11A1, CYP27A1
Membrane raft 2 EGFR, TNF
focal adhesion 1 EGFR
intracellular vesicle 1 EGFR
receptor complex 2 EGFR, VDR
ciliary basal body 1 ALB
chromatin 1 VDR
phagocytic cup 1 TNF
centriole 1 ALB
spindle pole 1 ALB
blood microparticle 1 ALB
endosome lumen 1 INS
cell body 1 EPO
basal plasma membrane 1 EGFR
synaptic membrane 1 EGFR
secretory granule lumen 2 EPO, INS
Golgi lumen 3 BGLAP, FGF23, INS
endoplasmic reticulum lumen 5 ALB, BGLAP, FGF23, IL6, INS
platelet alpha granule lumen 1 ALB
transport vesicle 1 INS
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 INS
neuronal dense core vesicle 1 CALCA
clathrin-coated endocytic vesicle membrane 1 EGFR
multivesicular body, internal vesicle lumen 1 EGFR
Shc-EGFR complex 1 EGFR
[Tumor necrosis factor, soluble form]: Secreted 1 TNF
interleukin-6 receptor complex 1 IL6
ciliary transition fiber 1 ALB
interleukin-28 receptor complex 1 IFNLR1
[C-domain 2]: Secreted 1 TNF
[Tumor necrosis factor, membrane form]: Membrane 1 TNF
[C-domain 1]: Secreted 1 TNF


文献列表

  • Chang Fengjin, Zhou Peng, L I Guoying, Zhang Weizhi, Zhang Yanyan, Peng Daiyin, Chen Guangliang. Taohong Siwu decoction ameliorates atherosclerosis in rats possibly through toll-like receptor 4/myeloid differentiation primary response protein 88/nuclear factor-κB signal pathway. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan. 2024 Feb; 44(1):103-112. doi: 10.19852/j.cnki.jtcm.20231215.003. [PMID: 38213245]
  • Shuhei Kido, Etsuo Chosa, Ryusuke Tanaka. The effect of six dried and UV-C-irradiated mushrooms powder on lipid oxidation and vitamin D contents of fish meat. Food chemistry. 2023 Jan; 398(?):133917. doi: 10.1016/j.foodchem.2022.133917. [PMID: 35987007]
  • Anja C Bailer, Sophie Philipp, Shabnam Staudt, Thomas Weidauer, Michael Kiehntopf, Stefan Lorkowski, Gabriele I Stangl, Christine Dawczynski. UVB-exposed wheat germ oil increases serum 25-hydroxyvitamin D2 without improving overall vitamin D status: a randomized controlled trial. European journal of nutrition. 2022 Aug; 61(5):2571-2583. doi: 10.1007/s00394-022-02827-w. [PMID: 35220442]
  • Dietmar Enko, Andreas Meinitzer, Sieglinde Zelzer, Markus Herrmann, Katharina Artinger, Alexander R Rosenkranz, Sabine Zitta. Vitamin D metabolism in living kidney donors before and after organ donation. Clinical chemistry and laboratory medicine. 2022 07; 60(8):1218-1224. doi: 10.1515/cclm-2022-0148. [PMID: 35514251]
  • Mohamed El-Boshy, Aiman Alsaegh, Ahmed H Qasem, Ramya A Sindi, Abdelghany H Abdelghany, Hossam Gadalla, Doha Reda, Firas Azzeh, Shakir Idris, Jawwad Ahmad, Bassem Refaat. Enhanced renoprotective actions of Paricalcitol and omega-3 fatty acids co-therapy against diabetic nephropathy in rat. Journal of advanced research. 2022 05; 38(?):119-129. doi: 10.1016/j.jare.2021.08.010. [PMID: 35572411]
  • Naowanit Nata, Wittaya Siricheepchaiyan, Ouppatham Supasyndh, Bancha Satirapoj. Efficacy of high versus conventional dose of ergocalciferol supplementation on serum 25-hydroxyvitamin D and interleukin-6 levels among hemodialysis patients with vitamin D deficiency: A multicenter, randomized, controlled study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2022 Apr; 26(2):378-386. doi: 10.1111/1744-9987.13722. [PMID: 34378863]
  • Galya Bigman. Vitamin D metabolites, D3 and D2, and their independent associations with depression symptoms among adults in the United States. Nutritional neuroscience. 2022 Apr; 25(4):648-656. doi: 10.1080/1028415x.2020.1794422. [PMID: 32684140]
  • Ojars Balcers, Ulises Miranda, Rita Veilande. Study of ergocalciferol and cholecalciferol (Vitamin D): Modeled optical properties and optical detection using absorption and Raman spectroscopy. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2022 Mar; 269(?):120725. doi: 10.1016/j.saa.2021.120725. [PMID: 34929622]
  • Shannon Galyean, David Syn, Hadil S Subih, Mallory Boylan. Improving vitamin D status in bariatric surgery subjects with monthly high-dose ergocalciferol. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition. 2022 Mar; 92(2):109-117. doi: 10.1024/0300-9831/a000728. [PMID: 34521264]
  • Jing-Wan Qi, Bing Huang, Shuang Wang, Dan Song, Jing Xu, Ying Cui, Bin Guo. Association Between Plasma Vitamin D2 and Type 2 Diabetes Mellitus. Frontiers in endocrinology. 2022; 13(?):897316. doi: 10.3389/fendo.2022.897316. [PMID: 35721707]
  • Fatemeh Meshkini, Sepideh Soltani, Cain C T Clark, Vivian Tam, David Meyre, Omid Toupchian, Sahar Saraf-Bank, Shima Abdollahi. The effect of vitamin D supplementation on serum levels of fibroblast growth factor- 23: A systematic review and meta-analysis of randomized controlled trials. The Journal of steroid biochemistry and molecular biology. 2022 01; 215(?):106012. doi: 10.1016/j.jsbmb.2021.106012. [PMID: 34710560]
  • Niansong Wang, Yuting Xie, Gengru Jiang. Efficacy and safety of intravenous paricalcitol treatment in Chinese hemodialysis patients: a real-world database analysis. Annals of palliative medicine. 2022 Jan; 11(1):225-239. doi: 10.21037/apm-21-3966. [PMID: 35144414]
  • Nipith Charoenngam, Michael F Holick. Marked Underestimation of Serum 25-hydroxyvitamin D Concentrations by The Abbot Architect Chemiluminescent Microparticle Immunoassay in Patients Receiving Vitamin D2 Supplementation. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2022 Jan; 28(1):122-123. doi: 10.1016/j.eprac.2021.10.002. [PMID: 34656785]
  • M Miedziaszczyk, I Idasiak-Piechocka, O W Wiśniewski, K Lacka. A systematic review of the pharmacotherapy of secondary hyperparathyroidism (SHPT) in grades 3-5 Chronic Kidney Disease (CKD). European review for medical and pharmacological sciences. 2022 Jan; 26(1):232-239. doi: 10.26355/eurrev_202201_27773. [PMID: 35049000]
  • Charles W Bishop, Stephen A Strugnell, Philipp Csomor, Edelgard Kaiser, Akhtar Ashfaq. Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism. American journal of nephrology. 2022; 53(6):446-454. doi: 10.1159/000524289. [PMID: 35551374]
  • Hina L Nizami, Parmeshwar B Katare, Pankaj Prabhakar, Ramu Adela, Soumalya Sarkar, Sudheer Arava, Praloy Chakraborty, Subir K Maulik, Sanjay K Banerjee. Paricalcitol Attenuates Metabolic Syndrome-Associated Heart Failure through Enhanced Mitochondrial Fusion. Oxidative medicine and cellular longevity. 2022; 2022(?):5554290. doi: 10.1155/2022/5554290. [PMID: 35726330]
  • Bin Wang, Jing-Yi Qian, Tao-Tao Tang, Li-Lu Lin, Nan Yu, Hong-Lei Guo, Wei-Jie Ni, Ling-Li Lv, Yi Wen, Zuo-Lin Li, Min Wu, Jing-Yuan Cao, Bi-Cheng Liu. VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy. Diabetes. 2021 11; 70(11):2639-2651. doi: 10.2337/db21-0205. [PMID: 34376476]
  • Jing Huang, Qi An, Bo-Miao Ju, Jing Zhang, Ping Fan, Lan He, Lei Wang. Role of vitamin D/VDR nuclear translocation in down-regulation of NF-κB/NLRP3/caspase-1 axis in lupus nephritis. International immunopharmacology. 2021 Nov; 100(?):108131. doi: 10.1016/j.intimp.2021.108131. [PMID: 34536747]
  • Farhad Koohpeyma, Gholamhossein Ranjbar Omrani, Ali Zamani, Forough Saki. Effects of Paricalcitol on Body Composition in Vitamin D-Deficient Rats. Iranian journal of medical sciences. 2021 11; 46(6):468-474. doi: 10.30476/ijms.2020.85368.1503. [PMID: 34840387]
  • Raquel Martínez-Pulleiro, María García-Murias, Manuel Fidalgo-Díaz, Miguel Ángel García-González. Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Alport Syndrome: A Primer for Clinicians. International journal of molecular sciences. 2021 Oct; 22(20):. doi: 10.3390/ijms222011063. [PMID: 34681722]
  • Yue Qu, Yuche Wu, Hong Jiang. Research progress in the pharmacological actions of the multiple effects and selectivity of the vitamin D analogue paricalcitol: a narrative review. Annals of palliative medicine. 2021 10; 10(10):11177-11190. doi: 10.21037/apm-21-2249. [PMID: 34763476]
  • Rakesh Balachandar, Raghu Pullakhandam, Bharati Kulkarni, Harshpal Singh Sachdev. Relative Efficacy of Vitamin D2 and Vitamin D3 in Improving Vitamin D Status: Systematic Review and Meta-Analysis. Nutrients. 2021 Sep; 13(10):. doi: 10.3390/nu13103328. [PMID: 34684328]
  • Raman Kumar Marwaha, Aashima Dabas, Seema Puri, Mani Kalaivani, Vineet Dabas, Sangeeta Yadav, Arjun Dang, R Pullakhandam, Sushil Gupta, Archana Narang. Efficacy of Daily Supplementation of Milk Fortified With Vitamin D2 for Three Months in Healthy School Children: A Randomized Placebo Controlled Trial. Indian pediatrics. 2021 Sep; 58(9):820-825. doi: . [PMID: 34302325]
  • Jaruwan Ngamkam, Somratai Vadcharavivad, Nutthada Areepium, Titinun Auamnoy, Kullaya Takkavatakarn, Pisut Katavetin, Khajohn Tiranathanagul, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Paweena Susantitaphong. The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism. Scientific reports. 2021 09; 11(1):18006. doi: 10.1038/s41598-021-97587-8. [PMID: 34504264]
  • Jeong-Hoon Lim, Ju-Min Yook, Se-Hyun Oh, Soo-Jee Jeon, Hee Won Noh, Hee-Yeon Jung, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Park. Paricalcitol Improves Hypoxia-Induced and TGF-β1-Induced Injury in Kidney Pericytes. International journal of molecular sciences. 2021 Sep; 22(18):. doi: 10.3390/ijms22189751. [PMID: 34575914]
  • Izabela Bolesławska, Magdalena Kowalówka, Małgorzata Dobrzyńska, Marta Karaźniewicz-Łada, Juliusz Przysławski. Differences in the Concentration of Vitamin D Metabolites in Plasma Due to the Low-Carbohydrate-High-Fat Diet and the Eastern European Diet-A Pilot Study. Nutrients. 2021 Aug; 13(8):. doi: 10.3390/nu13082774. [PMID: 34444934]
  • María Dolores Arenas Jimenez, Emilio González-Parra, Marta Riera, Abraham Rincón Bello, Ana López-Herradón, Higini Cao, Sara Hurtado, Silvia Collado, Laura Ribera, Francesc Barbosa, Fabiola Dapena, Vicent Torregrosa, José-Jesús Broseta, Carlos Soto Montañez, Juan F Navarro-González, Rosa Ramos, Jordi Bover, Xavier Nogués-Solan, Marta Crespo, Adriana S Dusso, Julio Pascual. Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients. 2021 Jul; 13(8):. doi: 10.3390/nu13082559. [PMID: 34444716]
  • Ye Ding, Ping Hu, Yue Yang, Fangping Xu, Fang Li, Xiaolong Lu, Zhencheng Xie, Zhixu Wang. Impact of Maternal Daily Oral Low-Dose Vitamin A Supplementation on the Mother-Infant Pair: A Randomised Placebo-Controlled Trial in China. Nutrients. 2021 Jul; 13(7):. doi: 10.3390/nu13072370. [PMID: 34371880]
  • Sieglinde Zelzer, Florian Prüller, Pero Curcic, Zdenka Sloup, Magdalena Holter, Markus Herrmann, Harald Mangge. Vitamin D Metabolites and Clinical Outcome in Hospitalized COVID-19 Patients. Nutrients. 2021 Jun; 13(7):. doi: 10.3390/nu13072129. [PMID: 34206219]
  • Hasan Haci Yeter, Berfu Korucu, Elif Burcu Bali, Ulver Derici. Association between calcitriol and paricalcitol with oxidative stress in patients with hemodialysis. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition. 2021 Jun; 91(3-4):335-342. doi: 10.1024/0300-9831/a000641. [PMID: 32065560]
  • Laura Martínez-Arias, Sara Panizo, Cristina Alonso-Montes, Julia Martín-Vírgala, Beatriz Martín-Carro, Sara Fernández-Villabrille, Carmen García Gil-Albert, Carmen Palomo-Antequera, José Luis Fernández-Martín, María Piedad Ruiz-Torres, Adriana S Dusso, Natalia Carrillo-López, Jorge B Cannata-Andía, Manuel Naves-Díaz. Effects of calcitriol and paricalcitol on renal fibrosis in CKD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 04; 36(5):793-803. doi: 10.1093/ndt/gfaa373. [PMID: 33416889]
  • Angela Vidal, Rafael Rios, Carmen Pineda, Ignacio Lopez, Ana I Raya, Escolastico Aguilera-Tejero, Jose-Luis L Rivero. Increased 1,25(OH)2-Vitamin D Concentrations after Energy Restriction Are Associated with Changes in Skeletal Muscle Phenotype. Nutrients. 2021 Feb; 13(2):. doi: 10.3390/nu13020607. [PMID: 33673262]
  • Fadime Demir, Mustafa Demir, Hatice Aygun. Evaluation of the protective effect of paricalcitol and vitamin D3 at doxorubicin nephrotoxicity in rats with 99mTechnetium-dimercaptosuccinic acid renal scintigraphy and biochemical methods. Human & experimental toxicology. 2021 Feb; 40(2):274-283. doi: 10.1177/0960327120950010. [PMID: 32812453]
  • Siqing Jiang, Hao Zhang, Xin Li, Bin Yi, Lihua Huang, Zhaoxin Hu, Aimei Li, Jie Du, Yanchun Li, Wei Zhang. Vitamin D/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3/Caspase-1/GSDMD pyroptosis pathway. The Journal of steroid biochemistry and molecular biology. 2021 02; 206(?):105789. doi: 10.1016/j.jsbmb.2020.105789. [PMID: 33259938]
  • Atthakorn Jarusriwanna, Suchat Phusunti, Pojchong Chotiyarnwong, Aasis Unnanuntana. High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial. BMC geriatrics. 2021 01; 21(1):72. doi: 10.1186/s12877-021-02023-1. [PMID: 33478397]
  • Zhuolin Zhang, Lele Cai, Hong Wu, Xinglu Xu, Wenqing Fang, Xuan He, Xiao Wang, Xin Li. Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis. Frontiers in public health. 2021; 9(?):712027. doi: 10.3389/fpubh.2021.712027. [PMID: 34368073]
  • Mei Fong Leung, Peter Chi Keung Cheung. Vitamins D and D2 in Cultivated Mushrooms under Ultraviolet Irradiation and Their Bioavailability in Humans: A Mini-Review. International journal of medicinal mushrooms. 2021; 23(11):1-15. doi: 10.1615/intjmedmushrooms.2021040390. [PMID: 34936304]
  • Ting Hu, Han Li, Hongchuan Liu, Ling Cong, Lihong Liu, Zhuoling An. High throughput UHPLC-MS/MS method for the simultaneous quantification of six vitamin D metabolites: application for vitamin D determination in patients after liver or kidney transplantation. Analytical methods : advancing methods and applications. 2020 12; 12(46):5591-5600. doi: 10.1039/d0ay01088j. [PMID: 33174880]
  • Ronald M Evans, Scott M Lippman. Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing. Cell metabolism. 2020 11; 32(5):704-709. doi: 10.1016/j.cmet.2020.09.007. [PMID: 32941797]
  • Anja C Baur, Corinna Brandsch, Benita Steinmetz, Alexandra Schutkowski, Monika Wensch-Dorendorf, Gabriele I Stangl. Differential effects of vitamin D3 vs vitamin D2 on cellular uptake, tissue distribution and activation of vitamin D in mice and cells. The Journal of steroid biochemistry and molecular biology. 2020 11; 204(?):105768. doi: 10.1016/j.jsbmb.2020.105768. [PMID: 33035648]
  • Feng Xu, Dexing Dai, Ruoman Sun, Zhenming Liu, Xiaolin Lin, Lusha Li, Xiaoping Xing, Xiangbing Wang, Chunlin Li, Zhongjian Xie. Long-Term Bioavailability of Single Doses of Intramuscular Vitamin D2. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2020 Nov; 26(11):1244-1254. doi: 10.4158/ep-2020-0124. [PMID: 33471654]
  • Dominika Rozmus, Alicja Ciesielska, Janusz Płomiński, Roman Grzybowski, Ewa Fiedorowicz, Natalia Kordulewska, Huub Savelkoul, Elżbieta Kostyra, Anna Cieślińska. Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases. International journal of molecular sciences. 2020 Oct; 21(21):. doi: 10.3390/ijms21217822. [PMID: 33105665]
  • Kim C Ohaegbulam, Mohamed Swalih, Pranavkumar Patel, Miriam A Smith, Richard Perrin. Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series. American journal of therapeutics. 2020 Sep; 27(5):e485-e490. doi: 10.1097/mjt.0000000000001222. [PMID: 32804682]
  • Khaled Saad, Abobakr Abdelmoghny, Mohamed Diab Aboul-Khair, Yasser Farouk Abdel-Raheem, Eman Fathalla Gad, Ahmed El-Sayed Hammour, Bahaa Hawary, Asmaa M Zahran, Mohamd A Alblihed, Amira Elhoufey. Vitamin D Status in Egyptian Children With Allergic Rhinitis. Ear, nose, & throat journal. 2020 Sep; 99(8):508-512. doi: 10.1177/0145561319850814. [PMID: 31088298]
  • Sandra Rayego-Mateos, Jose Luis Morgado-Pascual, José Manuel Valdivielso, Ana Belén Sanz, Enrique Bosch-Panadero, Raúl R Rodrigues-Díez, Jesús Egido, Alberto Ortiz, Emilio González-Parra, Marta Ruiz-Ortega. TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease. Journal of the American Society of Nephrology : JASN. 2020 09; 31(9):2026-2042. doi: 10.1681/asn.2019111206. [PMID: 32631974]
  • Tomohiro Bito, Eri Okumura, Masaki Fujishima, Fumio Watanabe. Potential of Chlorella as a Dietary Supplement to Promote Human Health. Nutrients. 2020 Aug; 12(9):. doi: 10.3390/nu12092524. [PMID: 32825362]
  • Hatice Aygun, Nursah Basol, Serdar Savas Gul. Cardioprotective Effect of Paricalcitol on Amitriptyline-Induced Cardiotoxicity in Rats: Comparison of [99mTc]PYP Cardiac Scintigraphy with Electrocardiographic and Biochemical Findings. Cardiovascular toxicology. 2020 08; 20(4):427-436. doi: 10.1007/s12012-020-09569-3. [PMID: 32219715]
  • Hasan Sözel, Sadi Köksoy, Sebahat Ozdem, Fatih Yılmaz, Feyza Bora, F Fevzi Ersoy. Lymphocyte and monocyte vitamin D receptor expression during paricalcitol or calcitriol treatments in patients with stage 5 chronic kidney disease. International urology and nephrology. 2020 Aug; 52(8):1563-1570. doi: 10.1007/s11255-020-02475-1. [PMID: 32405698]
  • Jian Li, Nan Li, Shuangtong Yan, Minyan Liu, Banruo Sun, Yanhui Lu, Yinghong Shao. Doxercalciferol Alleviates Bone Deteriorations and Cartilage Degeneration in Aging Mice. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 2020 Aug; 128(8):540-547. doi: 10.1055/a-0754-1956. [PMID: 30380573]
  • Ryyan Hyder, Stuart M Sprague. Secondary Hyperparathyroidism in a Patient with CKD. Clinical journal of the American Society of Nephrology : CJASN. 2020 07; 15(7):1041-1043. doi: 10.2215/cjn.13411119. [PMID: 32461217]
  • Carlo Massimetti, Antonio Bellasi, Sandro Feriozzi. [Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 2020 Jun; 37(3):. doi: . [PMID: 32530156]
  • Lina H M Ahmed, Alexandra E Butler, Soha R Dargham, Aishah Latif, Amal Robay, Omar M Chidiac, Amin Jayyousi, Jassim Al Suwaidi, Ronald G Crystal, Stephen L Atkin, Charbel Abi Khalil. Association of vitamin D2 and D3 with type 2 diabetes complications. BMC endocrine disorders. 2020 May; 20(1):65. doi: 10.1186/s12902-020-00549-w. [PMID: 32414363]
  • Dangfeng Zhang, Lin Qiao, Ting Fu. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020 May; 125(?):109528. doi: 10.1016/j.biopha.2019.109528. [PMID: 32106388]
  • Michael F Holick. The D-Sparaging of Vitamin D2: How Physiologically and Pharmacologically Relevant Is It for the Clinician?. The Journal of clinical endocrinology and metabolism. 2020 04; 105(4):. doi: 10.1210/clinem/dgz290. [PMID: 31867669]
  • Ravi I Thadhani, Sophia Rosen, Norma J Ofsthun, Len A Usvyat, Lorien S Dalrymple, Franklin W Maddux, Jeffrey L Hymes. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis. Clinical journal of the American Society of Nephrology : CJASN. 2020 03; 15(3):384-391. doi: 10.2215/cjn.07960719. [PMID: 32111702]
  • Sushmita Banerjee, Surupa Basu, Shakil Akhtar, Rajiv Sinha, Ananda Sen, Jayati Sengupta. Free vitamin D levels in steroid-sensitive nephrotic syndrome and healthy controls. Pediatric nephrology (Berlin, Germany). 2020 03; 35(3):447-454. doi: 10.1007/s00467-019-04433-1. [PMID: 31845055]
  • Laura Salanova Villanueva, Yohana Gil Giraldo, Begoña Santos Sánchez-Rey, Abelardo Aguilera Peralta. Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patiente. Far beyond mineral bone disease regulation. Nefrologia. 2020 Mar; 40(2):171-179. doi: 10.1016/j.nefro.2019.08.001. [PMID: 31740151]
  • Kamyar Kalantar-Zadeh, Christopher S Hollenbeak, Roy Arguello, Sophie Snyder, Akhtar Ashfaq. The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD. Journal of medical economics. 2020 Mar; 23(3):308-315. doi: 10.1080/13696998.2019.1693385. [PMID: 31726882]
  • Qunfeng Wu, Xuening Wang, Kien Pham, Aesis Luna, George P Studzinski, Chen Liu. Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination. The Journal of steroid biochemistry and molecular biology. 2020 03; 197(?):105524. doi: 10.1016/j.jsbmb.2019.105524. [PMID: 31704246]
  • Graziella D'Arrigo, Patrizia Pizzini, Sebastiano Cutrupi, Rocco Tripepi, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali. FGF23 and the PTH response to paricalcitol in chronic kidney disease. European journal of clinical investigation. 2020 Feb; 50(2):e13196. doi: 10.1111/eci.13196. [PMID: 31863599]
  • Zhaoxin Hu, Hao Zhang, Bin Yi, Shikun Yang, Jun Liu, Jing Hu, Jianwen Wang, Ke Cao, Wei Zhang. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell death & disease. 2020 01; 11(1):73. doi: 10.1038/s41419-020-2256-z. [PMID: 31996668]
  • Pattranid Mueangpaisarn, Sumapa Chaiamnuay. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women. Aging clinical and experimental research. 2020 Jan; 32(1):41-48. doi: 10.1007/s40520-019-01151-4. [PMID: 30784012]
  • Eunjin Bae, Jin Hyun Kim, Myeong Hee Jung, Si Jung Jang, Tae Won Lee, Sehyun Jung, Seunghye Lee, Ha Nee Jang, Se-Ho Chang, Dong Jun Park. Paricalcitol Attenuates Contrast-Induced Acute Kidney Injury by Regulating Mitophagy and Senescence. Oxidative medicine and cellular longevity. 2020; 2020(?):7627934. doi: 10.1155/2020/7627934. [PMID: 33299530]
  • Xinghua Geng, Ermin Shi, Shiwei Wang, Yuzhi Song. A comparative analysis of the efficacy and safety of paricalcitol versus other vitamin D receptor activators in patients undergoing hemodialysis: A systematic review and meta-analysis of 15 randomized controlled trials. PloS one. 2020; 15(5):e0233705. doi: 10.1371/journal.pone.0233705. [PMID: 32470067]
  • Hege Kampen Pihlstrøm, Thor Ueland, Annika E Michelsen, Pål Aukrust, Franscesca Gatti, Clara Hammarström, Monika Kasprzycka, Junbai Wang, Guttorm Haraldsen, Geir Mjøen, Dag Olav Dahle, Karsten Midtvedt, Ivar Anders Eide, Anders Hartmann, Hallvard Holdaas. Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients. PloS one. 2020; 15(12):e0243759. doi: 10.1371/journal.pone.0243759. [PMID: 33326471]
  • Nakhoul Nakhoul, Tina Thawko, Evgeny Farber, Inbal Dahan, Hagar Tadmor, Rola Nakhoul, Anaam Hanut, Ghasan Salameh, Ibrahim Shagrawy, Farid Nakhoul. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model. Journal of diabetes research. 2020; 2020(?):7907605. doi: 10.1155/2020/7907605. [PMID: 33294462]
  • Gavin Dreyer, Julius Kieswich, Steven Harwood, Amrita Ahluwalia, Muhammad M Yaqoob. Ergocalciferol improves endothelial vasodilatory and vasoconstrictor function in an in vivo model of mild uraemia. Bioscience reports. 2019 12; 39(12):. doi: 10.1042/bsr20190711. [PMID: 31789348]
  • Adrian R Martineau, Kenneth E Thummel, Zhican Wang, David A Jolliffe, Barbara J Boucher, Simon J Griffin, Nita G Forouhi, Graham A Hitman. Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial. The Journal of clinical endocrinology and metabolism. 2019 12; 104(12):5831-5839. doi: 10.1210/jc.2019-00207. [PMID: 31199458]
  • Alexandra Schuster, Akram Al-Makki, Brian Shepler. Use of Paricalcitol as Adjunctive Therapy to Renin-Angiotensin-Aldosterone System Inhibition for Diabetic Nephropathy: A Systematic Review of the Literature. Clinical therapeutics. 2019 11; 41(11):2416-2423. doi: 10.1016/j.clinthera.2019.09.009. [PMID: 31601446]
  • Yan Liu, Liu Li, Bin Yi, Zhao-Xin Hu, Ai-Mei Li, Cheng Yang, Li Zheng, Hao Zhang. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell. Life sciences. 2019 Oct; 234(?):116755. doi: 10.1016/j.lfs.2019.116755. [PMID: 31415769]
  • Cristian Rodelo-Haad, Elvira Esquivias-Motta, Francisco Amaral-Neiva, Alejandro Martin-Malo, Pedro Aljama, Mariano Rodriguez. Reversing extraosseous calcifications. A case of breast uremic calcific arteriolopathy. The breast journal. 2019 09; 25(5):998-999. doi: 10.1111/tbj.13389. [PMID: 31187553]
  • Kristina Lundwall, Josefin Mörtberg, Fariborz Mobarrez, Stefan H Jacobson, Gun Jörneskog, Jonas Spaak. Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease - a randomized trial. BMC nephrology. 2019 08; 20(1):290. doi: 10.1186/s12882-019-1445-4. [PMID: 31370809]
  • Sahar M El Agaty. Cardioprotective effect of vitamin D2 on isoproterenol-induced myocardial infarction in diabetic rats. Archives of physiology and biochemistry. 2019 Jul; 125(3):210-219. doi: 10.1080/13813455.2018.1448423. [PMID: 29519157]
  • Hasan Koc, Hasan Hoser, Yalcin Akdag, Cemaliye Kendir, F Fevzi Ersoy. Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study. International urology and nephrology. 2019 Jul; 51(7):1261-1270. doi: 10.1007/s11255-019-02175-5. [PMID: 31161518]
  • Jie Du, Siqing Jiang, Zhaoxin Hu, Shiqi Tang, Yue Sun, Jinrong He, Zhi Li, Bin Yi, Jianwen Wang, Hao Zhang, Yan Chun Li. Vitamin D receptor activation protects against lipopolysaccharide-induced acute kidney injury through suppression of tubular cell apoptosis. American journal of physiology. Renal physiology. 2019 05; 316(5):F1068-F1077. doi: 10.1152/ajprenal.00332.2018. [PMID: 30864841]
  • Ming-Chao He, Zhe Shi, Nan-Nan Sha, Nan Chen, Shi-Yu Peng, Duan-Fang Liao, Man-Sau Wong, Xiao-Li Dong, Yong-Jun Wang, Ti-Fei Yuan, Yan Zhang. Paricalcitol alleviates lipopolysaccharide-induced depressive-like behavior by suppressing hypothalamic microglia activation and neuroinflammation. Biochemical pharmacology. 2019 05; 163(?):1-8. doi: 10.1016/j.bcp.2019.01.021. [PMID: 30703351]
  • D P Larner, C Jenkinson, R F Chun, C S J Westgate, J S Adams, M Hewison. Free versus total serum 25-hydroxyvitamin D in a murine model of colitis. The Journal of steroid biochemistry and molecular biology. 2019 05; 189(?):204-209. doi: 10.1016/j.jsbmb.2019.01.015. [PMID: 30710745]
  • Graziella D'arrigo, Patrizia Pizzini, Sebastiano Cutrupi, Rocco Tripepi, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali. Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2019 05; 34(5):819-824. doi: 10.1093/ndt/gfy085. [PMID: 29668990]
  • Ricardo Villa-Bellosta, Ignacio Mahillo-Fernández, Alberto Ortíz, Emilio González-Parra. Questioning the Safety of Calcidiol in Hemodialysis Patients. Nutrients. 2019 04; 11(5):. doi: 10.3390/nu11050959. [PMID: 31035488]
  • Joana Gameiro, Inês Duarte, Cristina Outerelo, José António Lopes. Uremic lion face syndrome. Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia. 2019 Apr; 41(2):304-305. doi: 10.1590/2175-8239-jbn-2018-0198. [PMID: 30720853]
  • Michalis Giakoumis, Costas Tsioufis, Kyriakos Dimitriadis, Makro Sonikian, Alexandros Kasiakogias, Eirini Andrikou, Theodoros Kalos, Dimitrios Konstantinidis, Konstantinos Filis, Dimitrios Petras, Dimitrios Tousoulis. Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2019 Mar; 60(2):108-113. doi: 10.1016/j.hjc.2017.12.010. [PMID: 29305902]
  • X Wang, M Nachliely, J S Harrison, M Danilenko, G P Studzinski. Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen. The Journal of steroid biochemistry and molecular biology. 2019 03; 187(?):166-173. doi: 10.1016/j.jsbmb.2018.11.015. [PMID: 30508644]
  • Tong Zhang, Hongbo Ju, Haojun Chen, Wen Wen. Comparison of Paricalcitol and Calcitriol in Dialysis Patients With Secondary Hyperparathyroidism: A Meta-Analysis of Randomized Controlled Studies. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2019 Feb; 23(1):73-79. doi: 10.1111/1744-9987.12760. [PMID: 30328270]
  • Carlo Massimetti, Gea Imperato, Sandro Feriozzi. [Correction of secondary hyperparathyroidism with paricalcitol in renal transplant improves left ventricular hypertrophy]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 2019 Feb; 36(1):. doi: . [PMID: 30758155]
  • Yang Liu, Ling-Yun Liu, Ye Jia, Mei-Yan Wu, Yan-Yan Sun, Fu-Zhe Ma. Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis. Drug design, development and therapy. 2019; 13(?):999-1009. doi: 10.2147/dddt.s176257. [PMID: 30992658]
  • Mariana P Cardoso, Luciano A L Pereira. Native vitamin D in pre-dialysis chronic kidney disease. Nefrologia. 2019 Jan; 39(1):18-28. doi: 10.1016/j.nefro.2018.07.004. [PMID: 30274806]
  • Osama M Ahmed, Tarek M Ali, Mohamed A Abdel Gaid, Ahmed A Elberry. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats. PloS one. 2019; 14(9):e0214349. doi: 10.1371/journal.pone.0214349. [PMID: 31527864]
  • Jung Sun Park, Hoon In Choi, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim. Paricalcitol attenuates indoxyl sulfate-induced apoptosis through the inhibition of MAPK, Akt, and NF-kB activation in HK-2 cells. The Korean journal of internal medicine. 2019 Jan; 34(1):146-155. doi: 10.3904/kjim.2016.298. [PMID: 28992684]
  • Akram Al-Makki, Kaitlin Frost, Sang-A Yun, Brian Overholser, Brian Shepler. Ergocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2019; 22(1):593-598. doi: 10.18433/jpps30581. [PMID: 31804923]
  • Adrian R Martineau, David A Jolliffe, Lauren Greenberg, John F Aloia, Peter Bergman, Gal Dubnov-Raz, Susanna Esposito, Davaasambuu Ganmaa, Adit A Ginde, Emma C Goodall, Cameron C Grant, Wim Janssens, Megan E Jensen, Conor P Kerley, Ilkka Laaksi, Semira Manaseki-Holland, David Mauger, David R Murdoch, Rachel Neale, Judy R Rees, Steve Simpson, Iwona Stelmach, Geeta Trilok Kumar, Mitsuyoshi Urashima, Carlos A Camargo, Christopher J Griffiths, Richard L Hooper. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health technology assessment (Winchester, England). 2019 01; 23(2):1-44. doi: 10.3310/hta23020. [PMID: 30675873]
  • Manuel Soto-Dávila, Katherinne Valderrama, Sabrina M Inkpen, Jennifer R Hall, Matthew L Rise, Javier Santander. Effects of Vitamin D2 (Ergocalciferol) and D3 (Cholecalciferol) on Atlantic Salmon (Salmo salar) Primary Macrophage Immune Response to Aeromonas salmonicida subsp. salmonicida Infection. Frontiers in immunology. 2019; 10(?):3011. doi: 10.3389/fimmu.2019.03011. [PMID: 32010129]
  • Brian Czaya, Wacharee Seeherunvong, Saurav Singh, Christopher Yanucil, Phillip Ruiz, Yasmir Quiroz, Alexander Grabner, Chryso Katsoufis, Sethuraman Swaminathan, Carolyn Abitbol, Bernardo Rodriguez-Iturbe, Christian Faul, Michael Freundlich. Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies. American journal of hypertension. 2019 01; 32(1):34-44. doi: 10.1093/ajh/hpy154. [PMID: 30329020]
  • Manca Oblak, Gregor Mlinšek, Aljoša Kandus, Jadranka Buturović-Ponikvar, Miha Arnol. Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial. Transplant international : official journal of the European Society for Organ Transplantation. 2018 12; 31(12):1391-1404. doi: 10.1111/tri.13323. [PMID: 30062716]
  • Qi Dai, Xiangzhu Zhu, JoAnn E Manson, Yiqing Song, Xingnan Li, Adrian A Franke, Rebecca B Costello, Andrea Rosanoff, Hui Nian, Lei Fan, Harvey Murff, Reid M Ness, Douglas L Seidner, Chang Yu, Martha J Shrubsole. Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial. The American journal of clinical nutrition. 2018 12; 108(6):1249-1258. doi: 10.1093/ajcn/nqy274. [PMID: 30541089]
  • Bahman Bashardoust, Anahita Zakeri, Nasrin Fouladi, Zeinab Izadi, Fariba Hosseini. Treatment Effect of Ergocalciferol on Bone Metabolism Indexes and Parathyroid Hormone in Hemodialysis Patients. Iranian journal of kidney diseases. 2018 Nov; 12(6):359-363. doi: . [PMID: 30595565]
  • Suvi T Itkonen, Elina T Pajula, Kirsten G Dowling, George Lj Hull, Kevin D Cashman, Christel Je Lamberg-Allardt. Poor bioavailability of vitamin D2 from ultraviolet-irradiated D2-rich yeast in rats. Nutrition research (New York, N.Y.). 2018 11; 59(?):36-43. doi: 10.1016/j.nutres.2018.07.008. [PMID: 30442231]
  • C Suebthawinkul, K Panyakhamlerd, P Yotnuengnit, A Suwan, N Chaiyasit, N Taechakraichana. The effect of vitamin D2 supplementation on muscle strength in early postmenopausal women: a randomized, double-blind, placebo-controlled trial. Climacteric : the journal of the International Menopause Society. 2018 10; 21(5):491-497. doi: 10.1080/13697137.2018.1480600. [PMID: 30095022]
  • Belinda Spoto, Patrizia Pizzini, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali. Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2018 10; 33(10):1764-1769. doi: 10.1093/ndt/gfx344. [PMID: 29304245]
  • Marc Vila Cuenca, Evelina Ferrantelli, Elisa Meinster, Stephan M Pouw, Igor Kovačević, Renee X de Menezes, Hans W Niessen, Robert H J Beelen, Peter L Hordijk, Marc G Vervloet. Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability. Journal of the American Heart Association. 2018 09; 7(17):e008776. doi: 10.1161/jaha.118.008776. [PMID: 30371149]